Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XAV-19 in COVID-19 Induced Moderate Pneumonia
NCT04453384Phase 2Completed
- Sponsor
- CHU de Nantes
- Start
- Sep 2020
- Primary completion
- May 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of xav-19 in COVID-19 pneumonia, sponsored by CHU de Nantes. Started Sep 2020; status: completed.
02
Drugs
xav-19
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04453384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04453384.